TNF and systemic inflammatory response syndrome: The anti-inflammatory properties manifest by inhibition of the synthesis of TNF and nuclear transcription factor NF-κB, and by blocking the adhesion of leukocytes; thanks to these properties, the endogenous APC participates in the interruption of the coagulation cycle and inflammation, which are characteristic for SIRS [82,83].